Deregulation of Internal Ribosome Entry Site-Mediated p53 Translation in Cancer Cells with Defective p53 Response to DNA Damage

REFERENCES

• Giaccia AJ, Kastan MB. 1998. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 12:2973–2983. http://dx.doi.org/10.1101/gad.12.19.2973.
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Lane D, Levine AJ. 2000. Surfing the p53 network. Nature 408:307–310. http://dx.doi.org/10.1038/35042675.
   PubMed Web of Science ®Google Scholar
• Horn HF, Vousden KH. 2007. Coping with stress: multiple ways to activate p53. Oncogene 26:1306–1316. http://dx.doi.org/10.1038/sj.onc.1210263.
   PubMed Web of Science ®Google Scholar
• Halaby MJ, Yang DQ. 2007. p53 translational control: a new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics. Gene 395:1–7. http://dx.doi.org/10.1016/j.gene.2007.01.029.
   PubMed Web of Science ®Google Scholar
• Mosner J, Mummenbrauer T, Bauer C, Sczakiel G, Grosse F, Deppert W. 1995. Negative feedback regulation of wild-type p53 biosynthesis. EMBO J 14:4442–4449.
   PubMed Web of Science ®Google Scholar
• Takagi M, Absalon MJ, McLure KG, Kastan MB. 2005. Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 123:49–63. http://dx.doi.org/10.1016/j.cell.2005.07.034.
   PubMed Web of Science ®Google Scholar
• Gingras AC, Raught B, Sonenberg N. 1999. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68:913–963. http://dx.doi.org/10.1146/annurev.biochem.68.1.913.
   PubMed Web of Science ®Google Scholar
• Stoneley M, Willis AE. 2004. Cellular internal ribosome entry segments: structures, trans-acting factors and regulation of gene expression. Oncogene 23:3200–3207. http://dx.doi.org/10.1038/sj.onc.1207551.
   PubMed Web of Science ®Google Scholar
• Holcik M, Sonenberg N. 2005. Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 6:318–327. http://dx.doi.org/10.1038/nrm1618.
   PubMed Web of Science ®Google Scholar
• Yang DQ, Halaby MJ, Zhang Y. 2006. The identification of an internal ribosomal entry site in the 5′-untranslated region of p53 mRNA provides a novel mechanism for the regulation of its translation following DNA damage. Oncogene 25:4613–4619. http://dx.doi.org/10.1038/sj.onc.1209483.
   PubMed Web of Science ®Google Scholar
• Ray PS, Grover R, Das S. 2006. Two internal ribosome entry sites mediate the translation of p53 isoforms. EMBO Rep 7:404–410.
   PubMed Web of Science ®Google Scholar
• Candeias MM, Powell DJ, Roubalova E, Apcher S, Bourougaa K, Vojtesek B, Bruzzoni-Giovanelli H, Fahraeus R. 2006. Expression of p53 and p53/47 are controlled by alternative mechanisms of messenger RNA translation initiation. Oncogene 25:6936–6947. http://dx.doi.org/10.1038/sj.onc.1209996.
   PubMed Web of Science ®Google Scholar
• Sayan AE, Roperch JP, Sayan BS, Rossi M, Pinkoski MJ, Knight RA, Willis AE, Melino G. 2007. Generation of DeltaTAp73 proteins by translation from a putative internal ribosome entry site. Ann N Y Acad Sci 1095:315–324. http://dx.doi.org/10.1196/annals.1397.035.
   PubMedGoogle Scholar
• Kim DY, Kim W, Lee KH, Kim SH, Lee HR, Kim HJ, Jung Y, Choi JH, Kim KT. 2013. hnRNP Q regulates translation of p53 in normal and stress conditions. Cell Death Differ 20:226–234. http://dx.doi.org/10.1038/cdd.2012.109.
   PubMed Web of Science ®Google Scholar
• Grover R, Ray PS, Das S. 2008. Polypyrimidine tract binding protein regulates IRES-mediated translation of p53 isoforms. Cell Cycle 7:2189–2198. http://dx.doi.org/10.4161/cc.7.14.6271.
   PubMed Web of Science ®Google Scholar
• Montanaro L, Calienni M, Bertoni S, Rocchi L, Sansone P, Storci G, Santini D, Ceccarelli C, Taffurelli M, Carnicelli D, Brigotti M, Bonafe M, Trere D, Derenzini M. 2010. Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation. Cancer Res 70:4767–4777. http://dx.doi.org/10.1158/1538-7445.AM10-4767.
   PubMed Web of Science ®Google Scholar
• Bellodi C, Kopmar N, Ruggero D. 2010. Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita. EMBO J 29:1865–1876. http://dx.doi.org/10.1038/emboj.2010.83.
   PubMed Web of Science ®Google Scholar
• Sharathchandra A, Lal R, Khan D, Das S. 2012. Annexin A2 and PSF proteins interact with p53 IRES and regulate translation of p53 mRNA. RNA Biol 9:1429–1439. http://dx.doi.org/10.4161/rna.22707.
   PubMed Web of Science ®Google Scholar
• Weingarten-Gabbay S, Khan D, Liberman N, Yoffe Y, Bialik S, Das S, Oren M, Kimchi A. 2013. The translation initiation factor DAP5 promotes IRES-driven translation of p53 mRNA. Oncogene 33:611–618.
   PubMedGoogle Scholar
• Khan D, Katoch A, Das A, Sharathchandra A, Lal R, Roy P, Das S, Chattopadhyay S, Das S. 2015. Reversible induction of translational isoforms of p53 in glucose deprivation. Cell Death Differ 33:611–618. http://dx.doi.org/10.1038/onc.2012.626.
   Google Scholar
• Hellen CU, Sarnow P. 2001. Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev 15:1593–1612. http://dx.doi.org/10.1101/gad.891101.
   PubMed Web of Science ®Google Scholar
• Jackson RJ. 2005. Alternative mechanisms of initiating translation of mammalian mRNAs. Biochem Soc Trans 33:1231–1241. http://dx.doi.org/10.1042/BST20051231.
   PubMedGoogle Scholar
• Gasco M, Shami S, Crook T. 2002. The p53 pathway in breast cancer. Breast Cancer Res 4:70–76. http://dx.doi.org/10.1186/bcr426.
   PubMed Web of Science ®Google Scholar
• Fierro-Monti I, Mathews MB. 2000. Proteins binding to duplexed RNA: one motif, multiple functions. Trends Biochem Sci 25:241–246. http://dx.doi.org/10.1016/S0968-0004(00)01580-2.
   PubMed Web of Science ®Google Scholar
• Xu YH, Grabowski GA. 1999. Molecular cloning and characterization of a translational inhibitory protein that binds to coding sequences of the human acid beta-glucosidase and other mRNAs. Mol Genet Metab 68:441–454. http://dx.doi.org/10.1006/mgme.1999.2934.
   PubMed Web of Science ®Google Scholar
• Merrill MK, Gromeier M. 2006. The double-stranded RNA binding protein 76:NF45 heterodimer inhibits translation initiation at the rhinovirus type 2 internal ribosome entry site. J Virol 80:6936–6942. http://dx.doi.org/10.1128/JVI.00243-06.
   PubMed Web of Science ®Google Scholar
• Reichman TW, Parrott AM, Fierro-Monti I, Caron DJ, Kao PN, Lee CG, Li H, Mathews MB. 2003. Selective regulation of gene expression by nuclear factor 110, a member of the NF90 family of double-stranded RNA-binding proteins. J Mol Biol 332:85–98. http://dx.doi.org/10.1016/S0022-2836(03)00885-4.
   PubMedGoogle Scholar
• Hartman TR, Qian S, Bolinger C, Fernandez S, Schoenberg DR, Boris-Lawrie K. 2006. RNA helicase A is necessary for translation of selected messenger RNAs. Nat Struct Mol Biol 13:509–516. http://dx.doi.org/10.1038/nsmb1092.
   PubMed Web of Science ®Google Scholar
• Tuck SP, Crawford L. 1989. Characterization of the human p53 gene promoter. Mol Cell Biol 9:2163–2172.
   PubMed Web of Science ®Google Scholar
• Grover R, Sharathchandra A, Ponnuswamy A, Khan D, Das S. 2011. Effect of mutations on the p53 IRES RNA structure: implications for deregulation of the synthesis of p53 isoforms. RNA Biol 8:132–142. http://dx.doi.org/10.4161/rna.8.1.14260.
   PubMed Web of Science ®Google Scholar
• Concin N, Zeillinger C, Tong D, Stimpfl M, Konig M, Printz D, Stonek F, Schneeberger C, Hefler L, Kainz C, Leodolter S, Haas OA, Zeillinger R. 2003. Comparison of p53 mutational status with mRNA and protein expression in a panel of 24 human breast carcinoma cell lines. Breast Cancer Res Treat 79:37–46. http://dx.doi.org/10.1023/A:1023351717408.
   PubMed Web of Science ®Google Scholar
• Wasielewski M, Elstrodt F, Klijn JG, Berns EM, Schutte M. 2006. Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines. Breast Cancer Res Treat 99:97–101. http://dx.doi.org/10.1007/s10549-006-9186-z.
   PubMed Web of Science ®Google Scholar
• Vousden KH, Prives C. 2005. P53 and prognosis: new insights and further complexity. Cell 120:7–10. http://dx.doi.org/10.1016/S0092-8674(04)01252-8.
   PubMed Web of Science ®Google Scholar
• Parker LM, Fierro-Monti I, Mathews MB. 2001. Nuclear factor 90 is a substrate and regulator of the eukaryotic initiation factor 2 kinase double-stranded RNA-activated protein kinase. J Biol Chem 276:32522–32530. http://dx.doi.org/10.1074/jbc.M104408200.
   PubMed Web of Science ®Google Scholar
• Itahana K, Dimri G, Campisi J. 2001. Regulation of cellular senescence by p53. Eur J Biochem 268:2784–2791. http://dx.doi.org/10.1046/j.1432-1327.2001.02228.x.
   PubMedGoogle Scholar
• Schmitt E, Paquet C, Beauchemin M, Bertrand R. 2007. DNA-damage response network at the crossroads of cell-cycle checkpoints, cellular senescence and apoptosis. J Zhejiang Univ Sci B 8:377–397. http://dx.doi.org/10.1631/jzus.2007.B0377.
   PubMedGoogle Scholar
• Li Y, Yang DQ. 2010. The ATM inhibitor KU-55933 suppresses cell proliferation and induces apoptosis by blocking Akt in cancer cells with overactivated Akt. Mol Cancer Ther 9:113–125. http://dx.doi.org/10.1158/1535-7163.MCT-08-1189.
   PubMed Web of Science ®Google Scholar
• Meng Z, Jackson NL, Choi H, King PH, Emanuel PD, Blume SW. 2008. Alterations in RNA-binding activities of IRES-regulatory proteins as a mechanism for physiological variability and pathological dysregulation of IGF-IR translational control in human breast tumor cells. J Cell Physiol 217:172–183. http://dx.doi.org/10.1002/jcp.21486.
   PubMed Web of Science ®Google Scholar
• Lee CG, Eki T, Okumura K, Nogami M, Soares Vda C, Murakami Y, Hanaoka F, Hurwitz J. 1999. The human RNA helicase A (DDX9) gene maps to the prostate cancer susceptibility locus at chromosome band 1q25 and its pseudogene (DDX9P) to 13q22, respectively. Somat Cell Mol Genet 25:33–39. http://dx.doi.org/10.1023/B:SCAM.0000007138.44216.3a.
   PubMedGoogle Scholar
• MacGrogan D, Bookstein R. 1997. Tumour suppressor genes in prostate cancer. Semin Cancer Biol 8:11–19. http://dx.doi.org/10.1006/scbi.1997.0048.
   PubMed Web of Science ®Google Scholar
• Zhang S, Hemmerich P, Grosse F. 2007. Werner syndrome helicase (WRN), nuclear DNA helicase II (NDH II) and histone gammaH2AX are localized to the centrosome. Cell Biol Int 31:1109–1121. http://dx.doi.org/10.1016/j.cellbi.2007.03.027.
   PubMedGoogle Scholar
• Zhang S, Schlott B, Gorlach M, Grosse F. 2004. DNA-dependent protein kinase (DNA-PK) phosphorylates nuclear DNA helicase II/RNA helicase A and hnRNP proteins in an RNA-dependent manner. Nucleic Acids Res 32:1–10. http://dx.doi.org/10.1093/nar/gkg933.
   PubMed Web of Science ®Google Scholar
• Neplioueva V, Dobrikova EY, Mukherjee N, Keene JD, Gromeier M. 2010. Tissue type-specific expression of the dsRNA-binding protein 76 and genome-wide elucidation of its target mRNAs. PLoS One 5:e11710. http://dx.doi.org/10.1371/journal.pone.0011710.
   PubMedGoogle Scholar
• Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, Brennan J, MacLean KH, Han J, Chittenden T, Ihle JN, McKinnon PJ, Cleveland JL, Zambetti GP. 2003. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4:321–328. http://dx.doi.org/10.1016/S1535-6108(03)00244-7.
   PubMed Web of Science ®Google Scholar
• Garrison SP, Phillips DC, Jeffers JR, Chipuk JE, Parsons MJ, Rehg JE, Opferman JT, Green DR, Zambetti GP. 2012. Genetically defining the mechanism of Puma- and Bim-induced apoptosis. Cell Death Differ 19:642–649. http://dx.doi.org/10.1038/cdd.2011.136.
   PubMed Web of Science ®Google Scholar
• Kuilman T, Michaloglou C, Mooi WJ, Peeper DS. 2010. The essence of senescence. Genes Dev 24:2463–2479. http://dx.doi.org/10.1101/gad.1971610.
   PubMed Web of Science ®Google Scholar
• MacInnes AW, Amsterdam A, Whittaker CA, Hopkins N, Lees JA. 2008. Loss of p53 synthesis in zebrafish tumors with ribosomal protein gene mutations. Proc Natl Acad Sci U S A 105:10408–10413. http://dx.doi.org/10.1073/pnas.0805036105.
   PubMed Web of Science ®Google Scholar
• Fu L, Ma W, Benchimol S. 1999. A translation repressor element resides in the 3′ untranslated region of human p53 mRNA. Oncogene 18:6419–6424. http://dx.doi.org/10.1038/sj.onc.1203064.
   PubMedGoogle Scholar
• Chen J, Kastan MB. 2010. 5′-3′-UTR interactions regulate p53 mRNA translation and provide a target for modulating p53 induction after DNA damage. Genes Dev 24:2146–2156. http://dx.doi.org/10.1101/gad.1968910.
   PubMed Web of Science ®Google Scholar
• Mazan-Mamczarz K, Galban S, Lopez de Silanes I, Martindale JL, Atasoy U, Keene JD, Gorospe M. 2003. RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation. Proc Natl Acad Sci U S A 100:8354–8359. http://dx.doi.org/10.1073/pnas.1432104100.
   PubMed Web of Science ®Google Scholar
• Abdelmohsen K, Panda AC, Kang MJ, Guo R, Kim J, Grammatikakis I, Yoon JH, Dudekula DB, Noh JH, Yang X, Martindale JL, Gorospe M. 2014. 7SL RNA represses p53 translation by competing with HuR. Nucleic Acids Res 42:10099–10111. http://dx.doi.org/10.1093/nar/gku686.
   PubMed Web of Science ®Google Scholar